Shiek, Jenab R.

HRN: 28-71-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2026
03/26/2026
IV
56mg
Q24
PSNB T/c Aspiration Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: